Review

İntravezikal tedavilere yardımcı yöntemler
  • Hüseyin Cihan Demirel
Bull Urooncol 2011; 10: 13-17
Is intravesical BCG treatment necessary and/or sufficient?
  • Sinan Ekici
  • Polat Türker
Bull Urooncol 2013; 12: 22-25
Should all patients with non-muscle invaziv bladder tumor receive postoperative early single dose intravesical chemotherapy?
  • Sümer Baltacı
  • Ömer Gülpınar
Bull Urooncol 2012; 11: 30-33
Approach to the complications of intravesical therapy in bladder cancer
  • Turgay Gülecen
  • Cüneyd Özkürkçügil
Bull Urooncol 2012; 11: 34-40
Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer
  • Erem Bilensoy
  • Nazlı Erdoğar
  • Aydın N. Mungan
Bull Urooncol 2015; 14: 61-66 DOI: 10.4274/uob.246

Review

Intravesical Therapies in Non-muscle Invasive Bladder Tumors
  • Serdar Geyik
Bull Urooncol 2019; 18: 24-29 DOI: 10.4274/uob.galenos.2018.1116
Organ-Preserving Approach in Bladder Cancer: Assessment of the Current Situation
  • Reha Girgin
  • N. Aydın Mungan
Bull Urooncol 2018; 17: 63-67 DOI: 10.4274/uob.967

Original Article

The Effect of Tumor Localization and Clinicopathological Factors on Intravesical Recurrence and Survival in Primary Upper Urinary Tract Urothelial Tumors
  • Volkan İzol
  • Bahattin Kızılgök
  • Mutlu Değer
  • Yıldırım Bayazıt
  • Mustafa Zühtü Tansuğ
Bull Urooncol 2020; 19: 85-91 DOI: 10.4274/uob.galenos.2019.1432
Intravesical Mitomycin-C with Bladder Wall Hyperthermia in Intermediate and High-risk Non-muscle Invasive Bladder Cancers: Prospective Clinical Trial with a Singletreatment Arm
  • Abdullah Demirtaş
  • Şevket Tolga Tombul
  • Gökhan Sönmez
  • Akın Demirleğen
  • Türev Demirtaş
  • Atila Tatlışen
Bull Urooncol 2020; 19: 182-185 DOI: 10.4274/uob.galenos.2019.1314